PRELUDE — 2025 Investments

3 investments dated 2025 · listed companies and verified rows first · show all

Perelelperelelhealth.com inOct 2025SEC filingmedium confidence

Perelel makes doctor-formulated vitamin and supplement packs tailored to specific stages of women's hormonal lives, including trying to conceive, pregnancy trimesters, postpartum, motherhood, and perimenopause.

Direct to ConsumerFemTechWellness & FitnessSanta Monica, US

Victoria Thain Gioia(Executive Officer, Director, Promoter)inAlexandra Taylor(Executive Officer, Director, Promoter)Banafsheh Bayati(Co-Founder (board-certified OB/GYN))

BoardRachel Harris(Director)in

Board seatNeda Daneshzadeh· per SEC Form D · $4M raise · filed Nov 2025

Co-investorsSelva Ventures Unilever Ventures Willow Growth Partners Prelude Growth Partners

Dexaridexari.com 𝕏May 2025 · $2.3M

Dexari is a decentralized cryptocurrency platform that combines blockchain innovations to enable self-custodied crypto trading without intermediaries.

Crypto & Web3Fintech

Chuck Bradford(Founder)inSamuel Sramko(Founder)in

Co-investorsLemniscap

Tenortenor.finance in 𝕏Feb 2025 · $2.5M

Tenor is a platform providing onchain fixed-rate borrowing and lending infrastructure through an interface to the Morpho protocol.

Crypto & Web3Fintech

Co-investorsLattice Capital Cherry Ventures Coinbase Ventures Variant Fund very early Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.